Clinical Trial Update: A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne [Phase 3]

View source ↗

Summary

Completed Phase 3 trial evaluating the safety and efficacy of the KLOX Biophotonic System for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• KLOX Biophotonic System

Snippet

Sponsor: KLOX Technologies Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED